Characterization/NN
and/CC
purification/NN
of/IN
a/DT
protein/NN
kinase/NN
C/NN
substrate/NN
in/IN
human/JJ
B/NN
cells/NNS
./.
=====
Identification/NN
as/IN
lymphocyte-specific/JJ
protein/NN
1/CD
(/(
LSP1/NN
)/)
./.

Incubation/NN
of/IN
B-chronic/JJ
lymphocytic/JJ
leukemia/NN
(/(
B-CLL/NN
)/)
cells/NNS
with/IN
phorbol/NN
esters/NNS
resulted/VBD
in/IN
the/DT
phosphorylation/NN
of/IN
two/CD
major/JJ
PKC/NN
substrates/NNS
,/,
MARCKS/NN
(/(
myristoylated/VBN
,/,
alanine-rich/JJ
C/NN
kinase/NN
substrate/NN
)/)
and/CC
MRP/NN
(/(
MARCKS-related/JJ
protein/NN
)/)
,/,
and/CC
of/IN
a/DT
third/JJ
protein/NN
,/,
with/IN
an/DT
apparent/JJ
m.w./NN
of/IN
60,000/CD
that/WDT
was/VBD
the/DT
most/RBS
prominent/JJ
protein/NN
kinase/NN
C/NN
substrate/NN
in/IN
these/DT
cells/NNS
./.
=====
p60/NN
phosphorylation/NN
was/VBD
time/NN
and/CC
PMA/NN
dose/NN
dependent/JJ
,/,
and/CC
was/VBD
induced/VBN
by/IN
cell-permeable/JJ
diacylglycerol/NN
,/,
but/CC
not/RB
by/IN
inactive/JJ
phorbol/NN
esters/NNS
./.
=====
Two-dimensional/JJ
electrophoretic/JJ
analysis/NN
of/IN
the/DT
protein/NN
phosphorylation/NN
pattern/NN
from/IN
the/DT
B/NN
cell/NN
line/NN
CESS/NN
demonstrated/VBD
the/DT
identity/NN
between/IN
the/DT
p60/NN
protein/NN
expressed/VBN
in/IN
this/DT
cell/NN
line/NN
and/CC
that/DT
expressed/VBN
in/IN
B-CLL/NN
cells/NNS
./.
=====
p60/NN
was/VBD
purified/VBN
from/IN
CESS/NN
cells/NNS
and/CC
peptide/NN
microsequencing/NN
of/IN
this/DT
protein/NN
revealed/VBD
that/IN
it/PRP
was/VBD
lymphocyte-specific/JJ
protein/NN
1/CD
(/(
LSP1/NN
)/)
,/,
that/WDT
is/VBZ
here/RB
characterized/VBN
as/IN
the/DT
most/RBS
prominent/JJ
protein/NN
kinase/NN
C/NN
substrate/JJ
in/IN
B/NN
cells/NNS
./.